Melatonin therapy reduced mRNA expression of Slc9a3, Slc12a1 (encoding for NKCC2), and Atp1a1 (encoding for NaKATPase) in the H-MD+M group compared with those in the H-MD group. Here, SLC12A1 is linked to Menkes disease.